Navigation Links
CSHL team solves a protein complex's molecular structure to explain its role in gene silencing
Date:11/13/2011

Cold Spring Harbor, N.Y. A cell's genome maintains its integrity by organizing some of its regions into a super-compressed form of DNA called heterochromatin. In the comparatively simple organism fission yeast, a cellular phenomenon known as RNA interference (RNAi) plays an essential role in assembling heterochromatin, which keeps the compressed DNA in an inactive or "silent" state. Central to this process is a large protein complex that physically anchors various molecules involved in heterochromatin assembly to the chromatin fibers.

By probing the three dimensional structure of this protein complex, called RNA-Induced Initiation of Transcriptional gene Silencing (RITS), scientists from Cold Spring Harbor Laboratory (CSHL) and their collaborators at St. Jude's Research Hospital have discovered new details of how its various parts or "domains" contribute to heterochromatin assembly and gene silencing. The study appears in Nature Structural & Molecular Biology on Nov. 13.

"Heterochromatin formation relies on the RNAi pathway, and the RITS complex is the central, linking player that makes this possible," explains CSHL Professor and HHMI Investigator Leemor Joshua-Tor, Ph.D. The RITS complex is composed of three proteins, including Ago1, a key component of the cell's RNAi machinery. When Ago1 binds to small interfering RNAs (siRNAs) that originate from a specific genomic region, it helps shut down the activity of that genomic region.

The second member of the RITS complex is a protein called Chp1, which acts like a molecular Velcro that specifically attaches to those areas of chromatin that have been chemically marked by methyl groups. The third RITS component is a largely flexible protein called Tas3 that bridges Chp1 and Ago1.

"Our strategy to understand how these various modules of the RITS complex work has been to find out what these structures look like and how they connect to each other and to chromatin," says Josh
'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scripps research team solves structure of beneficial virus
2. Genetic sleuth solves glaucoma mystery
3. Brown biologist solves mystery of tropical grasses origin
4. A collaboration solves the herpes virus protein structure providing new drug therapy directions
5. Mystery dissolves with calcium pump discovery
6. Of mice and men: UNC-led team solves mouse genome dilemma
7. Team solves decades-old molecular mystery linked to blood clotting
8. DNA solves identities of Australian melons and loofah
9. Robot biologist solves complex problem from scratch
10. Photonic crystal biosensors detect protein-DNA interactions
11. Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... of the most debilitating symptoms of migraine and affects 80 ... physician, Dr. Zoltan Medgyessy of the Berolina Clinic in Lohne, ... antiemetic point on the inner wrist with an acupressure wristband ... migraine sufferers. He will be presenting his findings to ...
... and an international group of scientists have created ... losing pieces. Scientists led by Jianguo "Jack" Liu, ... built an integrated way to study a world that ... socioeconomic and environmental interactions over distances. They say "telecoupling" ...
... Efforts currently underway at the Energy Department,s National Renewable ... the research, development and testing of hydrogen and fuel ... of support from the Department,s Fuel Cell Technologies Office ... Hybrid Vehicles Advanced (FCHV-adv) on loan from Toyota. ...
Cached Biology News:Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress 2Telecoupling pulls pieces of sustainability puzzle together 2Telecoupling pulls pieces of sustainability puzzle together 3NREL drives toward the future with fuel cell EVs 2NREL drives toward the future with fuel cell EVs 3NREL drives toward the future with fuel cell EVs 4
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5gjj3/clinical ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services ... Global Version" report to their offering. ... of molecular diagnostics and pharmacogenics hold the promise ... that is moving out of the national and ...
(Date:5/5/2015)... , May 5, 2015 CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Suisse Antibody Day in New York ... Dr. McCarthy will present an overview of CytomX,s Probody ... drug conjugate programs. About CytomX Therapeutics ...
(Date:5/5/2015)... , May 5, 2015   Tocagen Inc. ... David R. Parkinson , M.D., a venture ... appointed to the board of directors of Tocagen. ... experience in oncology clinical development, including leading clinical ... global approvals of the cancer therapeutics Gleevec®, Femara®, ...
(Date:5/5/2015)... 05, 2015 GEA Pharma Systems, ... as recipients of the INTERPHEX Exhibitor Awards for ... their Portable, Continuous, Miniature and Modular (PCMM) platform. ... footprint, continuous processing equipment, smart control systems and ... powders and inactive ingredients into bulk tablets. ...
Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3
... Corporation has announced the,appointment of David A. Mann to ... Chairman of the Board,s audit committee., "Dave,s years ... biotechnology sector are an invaluable asset to Omeros,",stated Gregory ... an,important addition to our Board, and I expect that ...
... BN,ImmunoTherapeutics, Inc. has entered into a ... in the United States. Under the Cooperative,Research ... BN,ImmunoTherapeutics will jointly develop new immunotherapies for ... BN ImmunoTherapeutics has,rights to exclusively license intellectual ...
... Conference Call & Webcast Today at 2:00 p.m. CET, ... in the field of human gene therapy,today reported its results ... - Positive results of pivotal trial for Glybera(R) (AMT-011) ... treatment of Non-Alcoholic Steatotic Hepatitis - License for ...
Cached Biology Technology:Omeros Appoints David A. Mann to its Board of Directors 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 2Amsterdam Molecular Therapeutics Reports Half Year Results 2008 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 4
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: